patent/NO-20080457-L

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20080457-L

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-02
filingDate	2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9e718edad396442ff16488dd16e43b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98af2197a0cdae8ac81cfc4385afa6eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a4820d0ed25c1867433c055b5216189 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78b7c5e0ae673c1ede0e8119d0da962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e7f644a85e530c1d8600d4f32239b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54ffd867065e8d8157cfaded10c832b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf9786f1d26f0a558bc533e03e7daf40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49a5c5d7768dafe8ef4272198383b82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44605e6a4b90f5605100ea193b0e38cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ef2f7bee89647a16db20676096fae7
publicationDate	2008-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	NO-20080457-L
titleOfInvention	Chemical connections
abstract	The present invention is directed to novel indolecarboxamide derivatives. Specifically, the invention is directed to compounds of formula I: Formula (I) wherein R1, R2, R3, U and V are defined below, and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and may be useful in the treatment of disorders associated with adverse IKK2 (also known as IKKP) activity, such as rheumatoid arthritis, asthma and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is also further directed to methods for inhibiting IKK2 activity and the treatment of disorders associated therewith, using a compound of the present invention or a pharmaceutical composition comprising a compound of the invention.
priorityDate	2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID594832 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420236130

Total number of triples: 61.